KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash from Operations (2016 - 2025)

Gilead Sciences (GILD) has disclosed Cash from Operations for 17 consecutive years, with 3327000000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 11.83% year-over-year to 3327000000.0, compared with a TTM value of 10019000000.0 through Dec 2025, down 7.47%, and an annual FY2025 reading of 10019000000.0, down 7.47% over the prior year.
  • Cash from Operations was 3327000000.0 for Q4 2025 at Gilead Sciences, down from 4108000000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4309000000.0 in Q3 2024 and bottomed at 827000000.0 in Q2 2025.
  • Average Cash from Operations over 5 years is 2465450000.0, with a median of 2327000000.0 recorded in 2021.
  • Peak annual rise in Cash from Operations hit 145.53% in 2024, while the deepest fall reached 43.33% in 2024.
  • Year by year, Cash from Operations stood at 3205000000.0 in 2021, then decreased by 19.91% to 2567000000.0 in 2022, then fell by 15.5% to 2169000000.0 in 2023, then skyrocketed by 37.16% to 2975000000.0 in 2024, then grew by 11.83% to 3327000000.0 in 2025.
  • Business Quant data shows Cash from Operations for GILD at 3327000000.0 in Q4 2025, 4108000000.0 in Q3 2025, and 827000000.0 in Q2 2025.